These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18603628)

  • 1. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients.
    Balmaña J; Balaguer F; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Castells A; Syngal S;
    J Med Genet; 2008 Sep; 45(9):557-63. PubMed ID: 18603628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
    Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
    Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer.
    Bessa X; Alenda C; Paya A; Álvarez C; Iglesias M; Seoane A; Dedeu JM; Abulí A; Ilzarbe L; Navarro G; Pellise M; Balaguer F; Castellvi-Bel S; Llor X; Castells A; Jover R; Andreu M
    J Clin Oncol; 2011 Sep; 29(25):3374-80. PubMed ID: 21788563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.
    Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S
    Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome.
    Barrow E; Evans DG; McMahon R; Hill J; Byers R
    J Clin Pathol; 2011 Mar; 64(3):208-14. PubMed ID: 21177748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.
    Kastrinos F; Ojha RP; Leenen C; Alvero C; Mercado RC; Balmaña J; Valenzuela I; Balaguer F; Green R; Lindor NM; Thibodeau SN; Newcomb P; Win AK; Jenkins M; Buchanan DD; Bertario L; Sala P; Hampel H; Syngal S; Steyerberg EW;
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
    Rodríguez-Moranta F; Castells A; Andreu M; Piñol V; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Jover R; Payá A; Bessa X; Balaguer F; Cubiella J; Argüello L; Morillas JD; Bujanda L;
    Am J Gastroenterol; 2006 May; 101(5):1104-11. PubMed ID: 16696788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients.
    Balaguer F; Balmaña J; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Syngal S; Castells A;
    Gastroenterology; 2008 Jan; 134(1):39-46. PubMed ID: 18061181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.
    Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK
    Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
    Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
    Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K
    Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting.
    Ramsoekh D; Wagner A; van Leerdam ME; Dinjens WN; Steyerberg EW; Halley DJ; Kuipers EJ; Dooijes D
    Gut; 2008 Nov; 57(11):1539-44. PubMed ID: 18625694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
    Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
    JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.
    Serrano M; Lage P; Belga S; Filipe B; Francisco I; Rodrigues P; Fonseca R; Chaves P; Claro I; Albuquerque C; Pereira AD
    Fam Cancer; 2012 Dec; 11(4):571-8. PubMed ID: 22776989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.
    Bessa X; Ballesté B; Andreu M; Castells A; Bellosillo B; Balaguer F; Castellví-Bel S; Paya A; Jover R; Alenda C; Titó L; Martinez-Villacampa M; Vilella A; Xicola RM; Pons E; Llor X;
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):206-14. PubMed ID: 18096441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.